AIPLA Comments on Discretion to Institute Trials Before the Patent Trial and Appeal Board December 3, 2020

File Downloads

All documents are in PDF format.

The American Intellectual Property Law Association today filed a response to the USPTO’s October 20, 2020 request for comments on discretion to institute trials in inter partes review (IPR) and post grant review (PGR) proceedings before the Patent Trial and Appeal Board (PTAB). The USPTO’s request solicits input on whether rulemaking is necessary and the type of rules it should adopt, but does not propose any rules.

The AIPLA response is supportive, in principle, of notice and comment rulemaking on the PTAB’s discretion to institute that would start from the tests articulated in the PTAB’s General Plastics and NHK/Fintiv precedential opinions. AIPLA suggests  that, as a general rule, the same patent should not be subject to repeated trial proceedings before the PTAB. The response advocates for rules that would disfavor serial petitions, including a presumption that once a patent has been challenged in an AIA trial proceeding, that patent should not be subject to repeated subsequent challenges. The response also advocates for rules that would adopt current practice regarding parallel petitions—in which the PTAB disfavors multiple challenges except when the petitioner justifies simultaneously filing multiple petitions. Separately, the response supports rulemaking that would define the PTAB’s discretion to institute when parallel proceedings exist in the district courts.

Upcoming Events

  • 2026 IP Transactions Bootcamp

    February 12, 2026

    This in-person bootcamp is designed to provide practical insights and strategies for professionals working in intellectual property transactions. The day features a comprehensive agenda including: Panels and CLE Sessions: Learn about Working with Tech Transfer Offices, Strategies for successful collaborations between nonprofits and industry, and Protecting and monetizing an AI asset. Drafting and Negotiating Tips: Get practical advice on drafting and negotiating strategic collaboration and license agreements. Hands-on Workshop: Participate in a Mock licensing negotiation to put your skills to the test. Networking: Conclude the day with a dedicated Networking reception.
  • 2026 Patent Prosecution Bootcamp - Arlington, VA

    March 4 to 6, 2026   |   Up to 1235 minutes, including 60 Ethics minutes

    The 2026 Patent Prosecution Bootcamp is a comprehensive, CLE-accredited seminar that includes instructional lecture-style sessions with practical tips on U.S. and international patent preparation and prosecution, as well as hands-on interactive workshops that will walk you through drafting claims and responding to office actions.
  • 2026 Advanced Chemical Patent Practice Institute

    May 11 to 12, 2026   |   CLE calculations pending

    The Advanced Chemical & Biotech Patent Institute is an in-depth continuing legal education program tailored specifically for experienced patent practitioners in the chemical and biotech fields. This advanced course offers a comprehensive view from both prosecution and litigation perspectives, covering crucial topics relevant to practice in the U.S. and internationally.
  • 2026 Spring Meeting - San Francisco, CA

    May 13 to 15, 2026

    We’re excited to welcome you to the 2026 AIPLA Spring Meeting, where innovation, technology, and intellectual property come together to shape the future. San Francisco is ready for your ideas, energy, and passion for IP!
  • 2026 Trade Secret Summit

    June 1, 2026

    The AIPLA Trade Secret Summit is the leading trade secret conference in the nation, with speakers from across the spectrum of private practitioners, in-house counsel, government, and academia, as well as fantastic networking opportunities. CLE credits will be available.